Electrophysiological Pharmacology of the Nicotinic and Muscarinic Cholinergic Responses of Isolated Neuronal Somata From Locust Thoracic Ganglia
Open Access
- 1 September 1992
- journal article
- Published by The Company of Biologists in Journal of Experimental Biology
- Vol. 170 (1) , 203-233
- https://doi.org/10.1242/jeb.170.1.203
Abstract
Mechanically isolated neuronal somata from the thoracic ganglia of the locust Locusta migratoria remain electrophysiologically viable under current- or voltage-clamp in vitro for many hours. Nicotine and muscarine evoke different responses when pressure-microapplied to these somata. The response to acetylcholine is mainly nicotinic but contains a small muscarinic component. The nicotinic (ACh1) response is a rapid depolarisation accompanied by a decrease in membrane resistance. In voltage-clamped somata, the current mediating the ACh1 response is inward over the membrane potential range −30 to −110 mV, decreasing with depolarisation and with a projected reversal potential of about +20 mV. The muscarinic (ACh2) response is a slow depolarisation accompanied by a decrease in membrane resistance. In voltage-clamped somata, the current mediating the ACh2 response is inward, decreasing to zero at potentials of −80 to −90 mV. The ACh1 response is evoked by nicotine, anabasine, tetramethylammonium, DMPP and relatively high concentrations of the nitromethylene heterocycle insecticide, PMNI. Suberyldicholine or decamethonium evoke the response only when acetylcholine is present in the bathing saline. Nicotinic antagonists of the ACh1 response, in descending order of potency, are PMN1 >> α-bungarotoxin ≥ lobeline≥mecamylamine>trimethaphan camsylate>chlorisondamine>d-tubocurarine≥hexamethomium≥gallamine triethiodide≥tetraethylammonium. This response is also potently blocked by strychnine and more weakly blocked by δ-philanthotoxin, bicuculline and picrotoxin. The ACh2 response is evoked by muscarine, oxotremorine, arecoline, pilocarpine and, very weakly, by the M1-selective agonist McN-A-343. Muscarinic antagonists of the ACh2 response, in descending order of potency, are QNB≥scopolamine>atropine>4-DAMP (M3)≥benactyzine≥HHSiD (M1/M3)≥ pirenzepine (M1). QNX (M1), AF-DX116 (M2), gallamine triethiodide (M2) and methoctramine (M2) are almost or completely inactive.Keywords
This publication has 65 references indexed in Scilit:
- Cloning, sequence analysis and chromosome localization of a Drosophila muscarinic acetylcholine receptorFEBS Letters, 1989
- Molecular pharmacology of muscarinic receptor heterogeneityLife Sciences, 1989
- Characterization of muscarinic receptor subtypes in human tissuesLife Sciences, 1988
- Binding profile of a novel cardioselective muscarine receptor antagonist, AF-DX 116, to membranes of peripheral tissues and brain in the ratLife Sciences, 1986
- Block of locust muscle glutamate receptors by δ-philathotoxin occurs after receptor activationsBrain Research, 1982
- Properties of putative nicotinic and muscarinic cholinergic receptors in the central nervous system of Locusta migratoriaNeurochemistry International, 1981
- α‐Bungarotoxin Binding in House Fly Heads and Torpedo ElectroplaxJournal of Neurochemistry, 1981
- Muscarinic receptor in Drosophila melanogaster demonstrated by binding of [3H]quinuclidinyl benzilateFEBS Letters, 1977
- Demonstration of an α‐bungarotoxin‐binding nicotinic receptor in fliesFEBS Letters, 1977
- Comparison of the actions of iontophoretically applied acetylcholine and gamma aminobutyric acid with the EPSP and IPSP in cockroach central neuronsComparative and General Pharmacology, 1970